Safety Study of an Oral Vitamin D Analog in Postmenopausal Women
NCT01969656 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-07-27
Summary
Determine the safety of 2MD, a vitamin D analog, when administered orally once daily for 28 days in healthy normal postmenopausal women.
Conditions
- Postmenopausal Osteoporosis, Multiple Sites
Interventions
- DRUG
-
2MD
- DRUG
-
Calcitriol
- DRUG
Sponsors & Collaborators
-
Deltanoid Pharmaceuticals
lead INDUSTRY
Eligibility
- Min Age
- 45 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2004-06-30
More Related Trials
-
Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausal Women
NCT07310485 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder
NCT01607658 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
NCT03075956 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Estradiol Topical Products
NCT05645393 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women
NCT00566553 ·Status: COMPLETED ·Phase: NA
-
Estrogen Hormone Products
NCT05645406 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Progesterone Treatment in Female Smokers - 12
NCT00000295 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause
NCT05617287 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).
NCT07033013 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Efficacy and Safety of A High Molecular Weight, Natural Hyaluronic Acid Vaginal Gel in Women With Genitourinary Syndrome of Menopause
NCT05263102 ·Status: COMPLETED ·Phase: NA
-
The Effect of 12-week Supplementation With Olive Leaf Extract in Postmenopausal Women (FEMMED)
NCT05744453 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
NCT06908707 ·Status: COMPLETED ·Phase: PHASE1
-
Dienogest in Perimenopausal Women With Adenomyosis
NCT05751876 ·Status: COMPLETED
-
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
NCT02670785 ·Status: COMPLETED ·Phase: PHASE2
-
Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen
NCT03973099 ·Status: COMPLETED ·Phase: NA
-
A Study of Diclofenac Gel in Women With Primary Dysmenorrhea
NCT05752526 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
NCT01942668 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
NCT01085877 ·Status: COMPLETED ·Phase: PHASE1
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Gynodian® Depot in Women With Impaired Well-being
NCT00463450 ·Status: COMPLETED ·Phase: PHASE3
-
Transdermal Testosterone Nanoemulsion in Women Libido
NCT02445716 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women
NCT02859285 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo High-Throughput Assay for Vaginal Community Post-menopausal Women
NCT02415868 ·Status: COMPLETED
-
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
NCT04841499 ·Status: COMPLETED ·Phase: NA
-
COMPASS - COpenhagen MenoPAuSe Study
NCT07254429 ·Status: RECRUITING ·Phase: PHASE2